BCR-ABL kinase dynamics in drug resistance.

被引：0
|
作者：
Azam, M
Nardi, V
Shakespeare, W
Latek, RR
Bohacek, R
Veach, D
Clarkson, B
Sawyer, TK
Daley, GQ
机构：
[1] Childrens Hosp, Boston, MA 02115 USA
[2] Ariad Pharmaceut, Cambridge, MA USA
[3] Whitehead Inst, Cambridge, MA 02142 USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CLINICAL CANCER RESEARCH | 2005年 / 11卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9021S / 9022S
页数：2
相关论文
共 50 条
  • [1] BCR-ABL kinase dynamics and drug resistance
    Azam, M
    Nardi, V
    Shakespear, WC
    Latek, RR
    Veach, D
    Clarckson, B
    Bohacheck, R
    Sawyer, TK
    Daley, GQ
    BLOOD, 2005, 106 (11) : 565A - 565A
  • [2] OUTFLANKING BCR-ABL DRUG RESISTANCE
    Baweja, A.
    Ting, P.
    Colicelli, J.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2013, 61 (01) : 138 - 138
  • [3] Mechanisms of Resistance to BCR-ABL Kinase Inhibitors
    Diamond, Joana
    da Silva, Maria Gomes
    ACTA MEDICA PORTUGUESA, 2013, 26 (04): : 402 - 408
  • [4] Mechanisms of resistance to BCR-ABL and other kinase inhibitors
    Lamontanara, Allan Joaquim
    Gencer, Emel Basak
    Kuzyk, Orest
    Hantschel, Oliver
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2013, 1834 (07): : 1449 - 1459
  • [5] Bcr-abl tyrosine kinase inhibitorsAcquired drug resistance and various toxicities: case report
    Reactions Weekly, 2023, 1945 (1) : 132 - 132
  • [6] Development of Alkyne-Containing Pyrazolopyrimidines To Overcome Drug Resistance of Bcr-Abl Kinase
    Liu, Xu
    Kung, Alvin
    Malinoski, Brock
    Prakash, G. K. Surya
    Zhang, Chao
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (23) : 9228 - 9237
  • [7] Development of alkyne-containing pyrazolopyrimidines to overcome drug resistance of BCR-ABL kinase
    Liu, Xu
    Zhang, Chao
    Kung, Alvin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [8] Oncogenic kinase Bcr-Abl and its resistance to pharmacological inhibitors
    Krystof, Vladimir
    CHEMICKE LISTY, 2008, 102 (09): : 795 - 800
  • [9] Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia
    O'Hare, Thomas
    Eide, Christopher A.
    Deininger, Michael W. N.
    BLOOD, 2007, 110 (07) : 2242 - 2249
  • [10] Not all imatinib resistance in CML are BCR-ABL kinase domain mutations
    Yuan Wei
    Mats Hardling
    Bob Olsson
    Rahil Hezaveh
    Anne Ricksten
    Dick Stockelberg
    Hans Wadenvik
    Annals of Hematology, 2006, 85 : 841 - 847
12345